Home

David D. Chang, President and CEO: Allogene Therapeutics ALLO Sell · Filed 03/18

Trade details

Type
Insider sale
Amount
$117,974.61
Shares · price
47,763 sh · $2.47 a share
Held after
5,150,599 sh
Trade date
26/03/16
Filed
26/03/18
Days to filing
2 days

Sold 0.9% of holdings

Share of holding sold
0.9%

Allogene Therapeutics trades, last 26 weeks

What else happened in Allogene Therapeutics around then

Filed or reported within 30 days of the trade day · 02/14~04/15

David D. Chang's recent trades

  • David D. Chang

    Planned saleAllogene Therapeutics

    $117.8K

    Filed 03/16

  • David D. Chang

    SellAllogene Therapeutics

    $171.5K

    Filed 02/04

  • David D. Chang

    Planned saleAllogene Therapeutics

    $438.5K

    Filed 02/02

  • David D. Chang

    SellAllogene Therapeutics

    $91.5K

    Filed 25/03/18

  • David D. Chang

    Planned saleAllogene Therapeutics

    $91.5K

    Filed 25/03/14